Evidence map›Paper›PMID 30623290›Full record

SynthesisInternational urology and nephrology2019

Organ-sparing procedures in GU cancer: part 1-organ-sparing procedures in renal and adrenal tumors: a systematic review.

Raouf Seyam, Mahmoud I Khalil, Mohamed H Kamel, Waleed M Altaweel, Rodney Davis, Nabil K Bissada

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in International urology and nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Minimally Invasive Adrenal Surgery.Endocrinology and metabolism (Seoul, Korea) · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Raouf SeyamDepartment of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Mahmoud I KhalilDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Mohamed H KamelDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Waleed M AltaweelDepartment of Urology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Rodney DavisDepartment of Urology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Nabil K BissadaDepartment of Urology, Baylor College of Medicine and Michael E. De Bakey VA Medical Center, Houston, TX, USA. bissadan@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOrgan-sparing surgery (OSS) for the kidney and adrenals has emerged as the need for preservation of function is paramount in patients with poor functional reserve. As reports increasingly showed that oncological outcomes were equivalent to radical excision, elective OSS became a viable alternative in patients with otherwise normal reserve. In this review, we summarize the current knowledge of OSS for adrenal and renal tumors. MATERIALS AND

methodsPubMed, Web of Science and Cochrane Library Central Search were searched for recently published articles up to December 2017. The following keywords were used; "partial adrenalectomy", "adrenal sparing", "partial nephrectomy", "nephron sparing", "kidney/renal cancer".

resultsPartial adrenalectomy became an attractive alternative to total adrenalectomy avoiding adrenal insufficiency. Both minimally invasive surgery and ablative techniques were increasingly reported for adrenal OSS with adequate residual adrenal function and excellent oncological outcome. Radical nephrectomy remained for many years as the gold standard of treatment for organ-confined renal cell carcinoma. As the need to reduce the impact on renal function, more conservative approaches were utilized. Soon, the non-inferiority of nephron-sparing surgery to that of radical excision became evident and elective partial nephrectomy was gaining ground as the standard of care for small renal masses in patients with normal contralateral kidneys.

conclusionsHerein, we present a comprehensive review of the current status of OSS in renal and adrenal tumors.

Indexed as

Organ Sparing TreatmentsAblation TechniquesAdrenalectomyAdrenal Gland NeoplasmsAdrenal GlandsHumansKidneyKidney NeoplasmsMinimally Invasive Surgical ProceduresNephrectomyTreatment OutcomeNephron sparingOrgan sparingPartial adrenalectomyPartial nephrectomy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.